Silence Therapeutics plc

Pharmaceutical company · London, England, United Kingdom · Nasdaq: SLN

Silence Therapeutics plc is a pharmaceutical company headquartered in London, England, United Kingdom. Its earliest recorded incorporation is in 1994. Its shares trade on Nasdaq under the ticker SLN. It has reported private securities offerings to the US SEC, most recently $45 million sold in a notice filed in 2021. It is registered with UK Companies House under company number 02992058.

Profile compiled from public records. Is this your company? Request a correction or update

Silence Therapeutics at a glance

Typepharmaceutical company
HeadquartersLondon, England, United Kingdom
Earliest incorporation on record1994
Stock listingNasdaq: SLN
SEC industryPharmaceutical Preparations
Registered activities (UK)Research and experimental development on biotechnology
UK company number02992058
SEC CIK1479615

What does Silence Therapeutics do?

Private fundraising reported to the SEC

4 Form D notices; the most recent reported $45.5 million sold (2021).

Frequently asked questions about Silence Therapeutics

Where is Silence Therapeutics headquartered?

Silence Therapeutics plc is headquartered in London, England, United Kingdom.

What does Silence Therapeutics do?

Silence Therapeutics plc is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Silence Therapeutics a public company?

Yes. Silence Therapeutics plc trades on Nasdaq under the ticker SLN.

When was Silence Therapeutics founded?

The earliest incorporation on record for Silence Therapeutics plc is in 1994, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Contains public sector information licensed under the Open Government Licence v3.0 (UK Companies House).

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.